Hypermutable bacterial pathogens exist at surprisingly high prevalence and benefit bacterial populations by promoting adaptation to selective environments, including resistance to antibiotics. Five hundred Haemophilus influenzae isolates were screened for an increased frequency of mutation to resistance to rifampicin, nalidixic acid and spectinomycin: of the 14 hypermutable isolates identified, 12 were isolated from cystic fibrosis (CF) sputum. Analysis by enterobacterial repetitive intergenic consensus (ERIC)-PCR and ribotyping identified eight distinct genetic fingerprints. The hypermutable phenotype of seven of the eight unique isolates was associated with polymorphisms in conserved sites of mutS. Four of the mutant mutS alleles were cloned and failed to complement the mutator phenotype of a mutS : : TSTE mutant of H. influenzae strain Rd KW20. Antibiotic susceptibility testing of the hypermutators identified one β-lactamase-negative ampicillin-resistant (BLNAR) isolate with two isolates producing β-lactamase. Six isolates from the same patient with CF, with the same genetic fingerprint, were clonal by multilocus sequence typing (MLST). In this clone, there was an evolution to higher MIC values for the antibiotics administered to the patient during the period in which the strains were isolated. Hypermutable H. influenzae with mutations in mutS are prevalent, particularly in the CF lung environment, and may be selected for and maintained by antibiotic pressure.
BaylissC. D.,
van de VenT.,
MoxonE. R.
2002; Mutations in polI but not mutSLH destabilize Haemophilus influenzae tetranucleotide repeats. EMBO 21:1465–1476[CrossRef]
BaylissC. D.,
SweetmanW. A.,
MoxonE. R.
2004; Mutations in Haemophilus influenzae mismatch repair genes increase mutation rates of dinucleotide repeat tracts but not dinucleotide repeat-driven pilin phase variation rates. J Bacteriol 186:2928–2935[CrossRef]
BrownE. W.,
LeClercJ. E.,
LiB.,
PayneW. L.,
CebulaT. A.
2001; Phylogenetic evidence for horizontal transfer of mutS alleles among naturally occurring Escherichia coli strains. J Bacteriol 183:1631–1644[CrossRef]
BucciC.,
LavitolaA.,
SalvatoreP.,
Del GiudiceL.,
MassardoD. R.,
BruniC. B.,
AlifanoP.
1999; Hypermutation in pathogenic bacteria: frequent phase variation in meningococci is a phenotypic trait of a specialized mutator biotype. Mol Cell 3:435–445[CrossRef]
CarmeliY.,
TroilletN.,
KarchmerA. W.,
SamoreM. H.
1999; Health and economic outcomes of antibiotic resistance in Pseudomonas aeruginosa. Arch Intern Med 159:1127–1132[CrossRef]
DawsonK. J.
1999; The dynamics of infinitesimally rare alleles, applied to the evolution of mutation rates and the expression of deleterious mutations. Theor Popul Biol 55:1–22[CrossRef]
DenamurE.,
LecointreG.,
DarluP.9 other authors2000; Evolutionary implications of the frequent horizontal transfer of mismatch repair genes. Cell 103:711–721[CrossRef]
DenamurE.,
BonacorsiS.,
GiraudA.8 other authors2002; High frequency of mutator strains among human uropathogenic Escherichia coli isolates. J Bacteriol 184:605–609[CrossRef]
DoernG. V.,
BrueggemannA. B.,
PierceG.,
HolleyH. P.Jr, RauchA.
1997; Antibiotic resistance among clinical isolates of Haemophilus influenzae in the United States in 1994 and 1995 and detection of beta-lactamase-positive strains resistant to amoxicillin-clavulanate: results of a national multicenter surveillance study. Antimicrob Agents Chemother 41:292–297
FleischmannR. D.,
AdamsM. D.,
WhiteO.37 other authors1995; Whole-genome random sequencing and assembly of Haemophilus influenzae Rd. Science 269:496–512[CrossRef]
GlickmanB. W.,
RadmanM.
1980; Escherichia coli mutator mutants deficient in methylation-instructed DNA mismatch correction. Proc Natl Acad Sci U S A 77:1063–1067[CrossRef]
Gomez-De-LeonP.,
SantosJ. I.,
CaballeroJ.,
GomezD.,
EspinosaL. E.,
MorenoI.,
PineroD.,
CraviotoA.
2000; Genomic variability of Haemophilus influenzae isolated from Mexican children determined by using enterobacterial repetitive intergenic consensus sequences and PCR. J Clin Microbiol 38:2504–2511
LeClercJ. E.,
LiB.,
PayneW. L.,
CebulaT. A.
1996; High mutation frequencies among Escherichia coli and Salmonella pathogens. Science 274:1208–1211[CrossRef]
LiB.,
TsuiH. C.,
LeClercJ. E.,
DeyM.,
WinklerM. E.,
CebulaT. A.
2003; Molecular analysis of mutS expression and mutation in natural isolates of pathogenic Escherichia coli. Microbiology 149:1323–1331[CrossRef]
LowA. S.,
MacKenzieF. M.,
GouldI. M.,
BoothI. R.
2001; Protected environments allow parallel evolution of a bacterial pathogen in a patient subjected to long-term antibiotic therapy. Mol Microbiol 42:619–630
MaidenM. C.,
BygravesJ. A.,
FeilE.10 other authors1998; Multilocus sequence typing: a portable approach to the identification of clones within populations of pathogenic microorganisms. Proc Natl Acad Sci U S A 95:3140–3145[CrossRef]
MartinezE.,
BartolomeB,
de la CruzF.
1988; pACYC184-derived cloning vectors containing the multiple cloning site and lacZ alpha reporter gene of pUC8/9 and pUC18/19 plasmids. Gene 68:159–162[CrossRef]
MaticI.,
RayssiguierC.,
RadmanM.
1995; Interspecies gene exchange in bacteria: the role of SOS and mismatch repair systems in evolution of species. Cell 80:507–515[CrossRef]
MedeirosA. A.,
LevesqueR.,
JacobyG. A.
1986; An animal source for the ROB-1 beta-lactamase of Haemophilus influenzae type b. Antimicrob Agents Chemother 29:212–215[CrossRef]
MendelmanP. M.,
RobertsM. C.,
SmithA. L.
1982; Mutation frequency of Haemophilus influenzae to rifampin resistance. Antimicrob Agents Chemother 22:531–533[CrossRef]
MendelmanP. M.,
ChaffinD. O.,
StullT. L.,
RubensC. E.,
MackK. D.,
SmithA. L.
1984; Characterization of non-beta-lactamase-mediated ampicillin resistance in Haemophilus influenzae. Antimicrob Agents Chemother 26:235–244[CrossRef]
MendelmanP. M.,
ChaffinD. O.,
KrilovL. R.,
KalaitzoglouG.,
SerfassD. A.,
OnayO.,
WileyE. A.,
OverturfG. D.,
RubinL. G.
1990b; Cefuroxime treatment failure of nontypable Haemophilus influenzae meningitis associated with alteration of penicillin-binding proteins. J Infect Dis 162:1118–1123[CrossRef]
MitchellM. A.,
SkowronekK.,
KaucL.,
GoodgalS. H.
1991; Electroporation of Haemophilus influenzae is effective for transformation of plasmid but not chromosomal DNA. Nucleic Acids Res 19:3625–3628[CrossRef]
NCCLS2001Performance Standards for Antimicrobial Susceptibility Testing. Approved standard M100-S11 Wayne, PA: National Committee for Clinical Laboratory Standards;
OliverA.,
CantonR.,
CampoP.,
BaqueroF.,
BlazquezJ.
2000; High frequency of hypermutable Pseudomonas aeruginosa in cystic fibrosis lung infection. Science 288:1251–1254[CrossRef]
OliverA.,
BaqueroF.,
BlazquezJ.
2002; The mismatch repair system (mutS,mutL and uvrD genes) in Pseudomonas aeruginosa: molecular characterization of naturally occurring mutants. Mol Microbiol 43:1641–1650[CrossRef]
PettigrewM. M.,
FoxmanB.,
EcevitZ.,
MarrsC. F.,
GilsdorfJ.
2002; Use of pulsed-field gel electrophoresis, enterobacterial repetitive intergenic consensus typing, and automated ribotyping to assess genomic variability among strains of nontypeable Haemophilus influenzae. J Clin Microbiol 40:660–662[CrossRef]
PowellM.,
WilliamsJ. D.
1988; In-vitro activity of cefaclor, cephalexin and ampicillin against 2458 clinical isolates of Haemophilus influenzae. J Antimicrob Chemother 21:27–31[CrossRef]
PrunierA. L.,
MalbrunyB.,
LauransM.,
BrouardJ.,
DuhamelJ. F.,
LeclercqR.
2003; High rate of macrolide resistance in Staphylococcus aureus strains from patients with cystic fibrosis reveals high proportions of hypermutable strains. J Infect Dis 187:1709–1716[CrossRef]
RayssiguierC.,
ThalerD. S.,
RadmanM.
1989; The barrier to recombination between Escherichia coli and Salmonella typhimurium is disrupted in mismatch-repair mutants. Nature 342:396–401[CrossRef]
RichardsonA. R.,
YuZ.,
PopovicT.,
StojiljkovicI.
2002; Mutator clones of Neisseria meningitidis in epidemic serogroup A disease. Proc Natl Acad Sci U S A 99:6103–6107[CrossRef]
SchaaperR. M.,
DunnR. L.
1987; Spectra of spontaneous mutations in Escherichia coli strains defective in mismatch correction: the nature of in vivo DNA replication errors. Proc Natl Acad Sci U S A 84:6220–6224[CrossRef]
SharmaA.,
KaurR.,
GangulyN. K.,
SinghP. D.,
ChakrabortiA.
2002; Subtype distribution of Haemophilus influenzae isolates from north India. J Med Microbiol 51:399–404
SteersE. E.,
FoltzL.,
GravesB. S.,
RidenJ.
1959; An inocula replicating apparatus for routine testing of bacterial susceptibility of antibiotics. Antibiot Chemother 9:307–311
SyriopoulouV. P.,
ScheifeleD. W.,
SackC. M.,
SmithA. L.
1979; Effect of inoculum size on the susceptibility of Haemophilus influenzae b to beta-lactam antibiotics. Antimicrob Agents Chemother 16:510–513[CrossRef]
TaddeiF.,
VulicM.,
RadmanM.,
MaticI.
1997b; Genetic variability and adaptation to stress. In Environmental Stress, Adaptation, and Evolution pp. 271–290 Edited by
BijlsmaR.,
LoeschckeV.
Basel, Switzerland: Birkhauser;
TangC. M.,
HoodD. W.,
MoxonE. R.
2001; Pathogenesis of Haemophilus influenzae Infections. In Principles of Bacterial Pathogenesis pp. 675–716 Edited by
GroismanE. A.
St Louis, MO: Academic Press;
ThompsonJ. D.,
HigginsD. G.,
GibsonT. J.
1994; clustal w: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res 22:4673–4680[CrossRef]
van BelkumA.,
DuimB.,
RegelinkA.,
MollerL.,
QuintW.,
van AlphenL.
1994; Genomic DNA fingerprinting of clinical Haemophilus influenzae isolates by polymerase chain reaction amplification: comparison with major outer-membrane protein and restriction fragment length polymorphism analysis. J Med Microbiol 41:63–68[CrossRef]
VegaR.,
SadoffH. L.,
PattersonM. J.
1976; Mechanisms of ampicillin resistance in Haemophilus influenzae type B. Antimicrob Agents Chemother 9:164–168[CrossRef]
WilcoxK.,
SmithH.
1975; Isolation and characterization of mutants of Haemophilus influenzae deficient in an adenosine 5′-triphosphate-dependent deoxyribonuclease activity. J Bacteriol 122:443–453